Logo image of ORIS

ORIENTAL RISE HOLDINGS LTD (ORIS) Stock Fundamental Analysis

NASDAQ:ORIS - Nasdaq - KYG6781A1022 - Common Stock - Currency: USD

0.8714  -0.02 (-2.64%)

After market: 0.8557 -0.02 (-1.8%)

Fundamental Rating

5

Overall ORIS gets a fundamental rating of 5 out of 10. We evaluated ORIS against 89 industry peers in the Food Products industry. While ORIS has a great health rating, its profitability is only average at the moment. ORIS has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year ORIS was profitable.
In the past year ORIS had a positive cash flow from operations.
ORIS Yearly Net Income VS EBIT VS OCF VS FCFORIS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2M 4M 6M 8M 10M

1.2 Ratios

ORIS's Return On Assets of 5.93% is fine compared to the rest of the industry. ORIS outperforms 73.03% of its industry peers.
The Return On Equity of ORIS (6.10%) is comparable to the rest of the industry.
With a Return On Invested Capital value of 4.78%, ORIS perfoms like the industry average, outperforming 55.06% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for ORIS is above the industry average of 7.60%.
The last Return On Invested Capital (4.78%) for ORIS is well below the 3 year average (11.00%), which needs to be investigated, but indicates that ORIS had better years and this may not be a problem.
Industry RankSector Rank
ROA 5.93%
ROE 6.1%
ROIC 4.78%
ROA(3y)13.65%
ROA(5y)N/A
ROE(3y)14.57%
ROE(5y)N/A
ROIC(3y)11%
ROIC(5y)N/A
ORIS Yearly ROA, ROE, ROICORIS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 5 10 15 20

1.3 Margins

ORIS has a Profit Margin of 18.84%. This is amongst the best in the industry. ORIS outperforms 95.51% of its industry peers.
In the last couple of years the Profit Margin of ORIS has declined.
With an excellent Operating Margin value of 18.73%, ORIS belongs to the best of the industry, outperforming 95.51% of the companies in the same industry.
In the last couple of years the Operating Margin of ORIS has declined.
Looking at the Gross Margin, with a value of 29.04%, ORIS is in the better half of the industry, outperforming 64.04% of the companies in the same industry.
In the last couple of years the Gross Margin of ORIS has declined.
Industry RankSector Rank
OM 18.73%
PM (TTM) 18.84%
GM 29.04%
OM growth 3Y-31.11%
OM growth 5YN/A
PM growth 3Y-30.79%
PM growth 5YN/A
GM growth 3Y-20.11%
GM growth 5YN/A
ORIS Yearly Profit, Operating, Gross MarginsORIS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 10 20 30 40 50

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ORIS is still creating some value.
Compared to 1 year ago, ORIS has more shares outstanding
There is no outstanding debt for ORIS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ORIS Yearly Shares OutstandingORIS Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M 20M
ORIS Yearly Total Debt VS Total AssetsORIS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

ORIS has an Altman-Z score of 8.36. This indicates that ORIS is financially healthy and has little risk of bankruptcy at the moment.
ORIS's Altman-Z score of 8.36 is amongst the best of the industry. ORIS outperforms 95.51% of its industry peers.
There is no outstanding debt for ORIS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.36
ROIC/WACC0.63
WACC7.57%
ORIS Yearly LT Debt VS Equity VS FCFORIS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 20M 40M 60M

2.3 Liquidity

ORIS has a Current Ratio of 24.80. This indicates that ORIS is financially healthy and has no problem in meeting its short term obligations.
ORIS has a better Current ratio (24.80) than 100.00% of its industry peers.
A Quick Ratio of 23.79 indicates that ORIS has no problem at all paying its short term obligations.
ORIS's Quick ratio of 23.79 is amongst the best of the industry. ORIS outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 24.8
Quick Ratio 23.79
ORIS Yearly Current Assets VS Current LiabilitesORIS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 10M 20M 30M 40M

0

3. Growth

3.1 Past

ORIS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -70.76%.
ORIS shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -26.95% yearly.
Looking at the last year, ORIS shows a very negative growth in Revenue. The Revenue has decreased by -42.06% in the last year.
The Revenue for ORIS have been decreasing by -12.44% on average. This is quite bad
EPS 1Y (TTM)-70.76%
EPS 3Y-26.95%
EPS 5YN/A
EPS Q2Q%-68.19%
Revenue 1Y (TTM)-42.06%
Revenue growth 3Y-12.44%
Revenue growth 5YN/A
Sales Q2Q%-37.76%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ORIS Yearly Revenue VS EstimatesORIS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 5M 10M 15M 20M

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 3.23 indicates a rather cheap valuation of ORIS.
ORIS's Price/Earnings ratio is rather cheap when compared to the industry. ORIS is cheaper than 96.63% of the companies in the same industry.
ORIS is valuated cheaply when we compare the Price/Earnings ratio to 26.31, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 3.23
Fwd PE N/A
ORIS Price Earnings VS Forward Price EarningsORIS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, ORIS is valued cheaper than 94.38% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.44
EV/EBITDA -4.35
ORIS Per share dataORIS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ORIS!.
Industry RankSector Rank
Dividend Yield N/A

ORIENTAL RISE HOLDINGS LTD

NASDAQ:ORIS (6/13/2025, 8:00:02 PM)

After market: 0.8557 -0.02 (-1.8%)

0.8714

-0.02 (-2.64%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.47%
Inst Owner ChangeN/A
Ins Owners86.44%
Ins Owner ChangeN/A
Market Cap19.18M
AnalystsN/A
Price TargetN/A
Short Float %2.56%
Short Ratio0.29
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 3.23
Fwd PE N/A
P/S 0.84
P/FCF 6.44
P/OCF 5.93
P/B 0.27
P/tB 0.27
EV/EBITDA -4.35
EPS(TTM)0.27
EY30.98%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.14
FCFY15.53%
OCF(TTM)0.15
OCFY16.87%
SpS1.03
BVpS3.19
TBVpS3.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.93%
ROE 6.1%
ROCE 6.05%
ROIC 4.78%
ROICexc 12.32%
ROICexgc 12.32%
OM 18.73%
PM (TTM) 18.84%
GM 29.04%
FCFM 13.11%
ROA(3y)13.65%
ROA(5y)N/A
ROE(3y)14.57%
ROE(5y)N/A
ROIC(3y)11%
ROIC(5y)N/A
ROICexc(3y)22.86%
ROICexc(5y)N/A
ROICexgc(3y)22.86%
ROICexgc(5y)N/A
ROCE(3y)14.51%
ROCE(5y)N/A
ROICexcg growth 3Y-34.59%
ROICexcg growth 5YN/A
ROICexc growth 3Y-34.59%
ROICexc growth 5YN/A
OM growth 3Y-31.11%
OM growth 5YN/A
PM growth 3Y-30.79%
PM growth 5YN/A
GM growth 3Y-20.11%
GM growth 5YN/A
F-Score4
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 23.29%
Cap/Sales 1.14%
Interest Coverage 31.04
Cash Conversion 60.36%
Profit Quality 69.6%
Current Ratio 24.8
Quick Ratio 23.79
Altman-Z 8.36
F-Score4
WACC7.57%
ROIC/WACC0.63
Cap/Depr(3y)60.73%
Cap/Depr(5y)N/A
Cap/Sales(3y)3.01%
Cap/Sales(5y)N/A
Profit Quality(3y)117.23%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-70.76%
EPS 3Y-26.95%
EPS 5YN/A
EPS Q2Q%-68.19%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-42.06%
Revenue growth 3Y-12.44%
Revenue growth 5YN/A
Sales Q2Q%-37.76%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-78.57%
EBIT growth 3Y-39.69%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-72.61%
FCF growth 3Y71.83%
FCF growth 5YN/A
OCF growth 1Y-74.39%
OCF growth 3Y-28.66%
OCF growth 5YN/A